Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CRON: Cronos Group Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
CRON
The Story
CRON
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Revenue growth
+34.8% / yr
Operating margin
-7.8%
ROIC
0.8%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
21.87×
Cronos Group Inc.
CRON
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Cronos Group Inc.
CRON
NASDAQ
·
USD
·
Closed
$2.83
−2.08%
$2.83
−$0.06 (2.08%)
52W Range
60th
pctl
Volume
0.62×
avg
Mkt Cap
1.06B
USD
P/E
-1280.8
TTM
Div Yield
–
ann
52W Range
60th
pctl
Volume
0.62×
avg
Market Cap
1.06B
USD
P/E Ratio
-1280.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings